Concepedia

Jouko Levijoki

JL

35

Publications

1.9K

Citations

22

H-Index

1995

Active since

Affiliations

Orion Corporation (Finland)(Current)

University of Helsinki

University of Szeged

Hungarian Academy of Sciences

University of Debrecen

Jouko Levijoki is an author at Orion Corporation (Finland) specializing in medicine, pharmacology, and physiology.

ORCID

Top concepts

Publications per year

1995–2020

35

Publications

35

Troponin C–Mediated Calcium Sensitization Induced by Levosimendan Does Not Impair Relaxation

Heimo Haikala, Erkki Nissinen, E Etemadzadeh et al. · Journal of Cardiovascular Pharmacology · 1995 · 226 citations

, , +17

Levosimendan Increases Diastolic Coronary Flow in Isolated Guinea-Pig Heart by Opening ATP-Sensitive Potassium Channels

Petri Kaheinen, Piero Pollesello, Jouko Levijoki et al. · Journal of Cardiovascular Pharmacology · 2001 · 159 citations

, , +16

Extracellular membrane vesicles from umbilical cord blood‐derived MSC protect against ischemic acute kidney injury, a feature that is lost after inflammatory conditioning

Lotta Kilpinen, Ulla Impola, Lotta Sankkila et al. · Journal of Extracellular Vesicles · 2013 · 158 citations · Full text

AMPK activator AICAR ameliorates ischaemia reperfusion injury in the rat kidney

Juha Lempiäinen, Piet Finckenberg, Jouko Levijoki et al. · British Journal of Pharmacology · 2012 · 125 citations

, , +22

The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig

Szabolcs Szilágyi, Piero Pollesello, Jouko Levijoki et al. · European Journal of Pharmacology · 2004 · 125 citations · Full text

Rows per page

1–5 of 35